Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial Carcinoma

The therapeutic benefit of immune checkpoint inhibitor monotherapy is limited to a subset of patients in urothelial carcinoma (UC). Previous studies showed the immunogenicity of cisplatin and irradiation. Here, we investigated whether chemoradiotherapy (CRT), a combination of cisplatin and irradiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Hiroshi, Yoshida, Soichiro, Kijima, Toshiki, Nakamura, Yuki, Fukuda, Shohei, Uehara, Sho, Yasuda, Yosuke, Tanaka, Hajime, Yokoyama, Minato, Matsuoka, Yoh, Fujii, Yasuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825793/
https://www.ncbi.nlm.nih.gov/pubmed/33430352
http://dx.doi.org/10.3390/ijms22020535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825793/
https://www.ncbi.nlm.nih.gov/pubmed/33430352
http://dx.doi.org/10.3390/ijms22020535

Ejemplares similares